These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20460512)

  • 1. Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status.
    Ostrander JH; McMahon CM; Lem S; Millon SR; Brown JQ; Seewaldt VL; Ramanujam N
    Cancer Res; 2010 Jun; 70(11):4759-66. PubMed ID: 20460512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of Breast Cancer Metabolism Using Multimodal Nonlinear Optical Microscopy of Cellular Lipids and Redox State.
    Hou J; Williams J; Botvinick EL; Potma EO; Tromberg BJ
    Cancer Res; 2018 May; 78(10):2503-2512. PubMed ID: 29535219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells.
    Ikeda H; Taira N; Hara F; Fujita T; Yamamoto H; Soh J; Toyooka S; Nogami T; Shien T; Doihara H; Miyoshi S
    Breast Cancer Res; 2010; 12(3):R43. PubMed ID: 20579400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput measurements of the optical redox ratio using a commercial microplate reader.
    Cannon TM; Shah AT; Walsh AJ; Skala MC
    J Biomed Opt; 2015 Jan; 20(1):010503. PubMed ID: 25634108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer.
    Reijm EA; Jansen MP; Ruigrok-Ritstier K; van Staveren IL; Look MP; van Gelder ME; Sieuwerts AM; Sleijfer S; Foekens JA; Berns EM
    Breast Cancer Res Treat; 2011 Jan; 125(2):387-94. PubMed ID: 20306127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.
    Ito T; Kamijo S; Izumi H; Kohno K; Amano J; Ito K
    Breast Cancer Res Treat; 2012 May; 133(1):145-59. PubMed ID: 21863258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Biomarker for Triple-Negative Breast Cancer Invasiveness by Optical Redox Imaging.
    Feng M; Xu HN; Jiang J; Li LZ
    Adv Exp Med Biol; 2021; 1269():247-251. PubMed ID: 33966225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.
    Creighton CJ; Massarweh S; Huang S; Tsimelzon A; Hilsenbeck SG; Osborne CK; Shou J; Malorni L; Schiff R
    Cancer Res; 2008 Sep; 68(18):7493-501. PubMed ID: 18794137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Indexing of the Invasiveness of Breast Cancer Cells by Mitochondrial Redox Ratios.
    Sun N; Xu HN; Luo Q; Li LZ
    Adv Exp Med Biol; 2016; 923():121-127. PubMed ID: 27526133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium.
    Jensen J; Kitlen JW; Briand P; Labrie F; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2003 Mar; 84(4):469-78. PubMed ID: 12732292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol regulates Tumor Necrosis Factor-α expression and secretion in Estrogen Receptor positive breast cancer cells.
    To SQ; Cheung V; Lazarus KA; Knower KC; Clyne CD
    Mol Cell Endocrinol; 2014 Aug; 394(1-2):21-8. PubMed ID: 25004254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
    Sui M; Jiang D; Hinsch C; Fan W
    Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of Cyr61 in human breast cancer cell lines.
    Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
    Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.
    Honorat M; Mesnier A; Vendrell J; Guitton J; Bieche I; Lidereau R; Kruh GD; Dumontet C; Cohen P; Payen L
    Endocr Relat Cancer; 2008 Mar; 15(1):125-38. PubMed ID: 18310281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
    Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
    Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes.
    Jiang J; Feng M; Jacob A; Li LZ; Xu HN
    Adv Exp Med Biol; 2021; 1269():253-258. PubMed ID: 33966226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-alpha-interacting cytokeratins potentiate the antiestrogenic activity of fulvestrant.
    Long X; Fan M; Nephew KP
    Cancer Biol Ther; 2010 Mar; 9(5):389-96. PubMed ID: 20061804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia reduces hormone responsiveness of human breast cancer cells.
    Kurebayashi J; Otsuki T; Moriya T; Sonoo H
    Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.
    Bayliss J; Hilger A; Vishnu P; Diehl K; El-Ashry D
    Clin Cancer Res; 2007 Dec; 13(23):7029-36. PubMed ID: 18056179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.